428 related articles for article (PubMed ID: 24328511)
1. The glycemic/metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus.
Ono Y; Nakamura A; Cho KY; Nomoto H
Expert Opin Pharmacother; 2014 Feb; 15(3):311-24. PubMed ID: 24328511
[TBL] [Abstract][Full Text] [Related]
2. Glycemic/metabolic responses to identical meal tolerance tests at breakfast, lunch and dinner in Japanese patients with type 2 diabetes mellitus treated with a dipeptidyl peptidase-4 inhibitor and the effects of adding a mitiglinide/voglibose fixed-dose combination.
Ono Y; Kamoshima H; Nakamura A; Nomoto H
Expert Opin Pharmacother; 2014 Sep; 15(13):1785-95. PubMed ID: 25046055
[TBL] [Abstract][Full Text] [Related]
3. Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus.
Ono Y; Kameda H; Cho KY
Expert Opin Pharmacother; 2013 Mar; 14(4):361-70. PubMed ID: 23414242
[TBL] [Abstract][Full Text] [Related]
4. Fasting until noon triggers increased postprandial hyperglycemia and impaired insulin response after lunch and dinner in individuals with type 2 diabetes: a randomized clinical trial.
Jakubowicz D; Wainstein J; Ahren B; Landau Z; Bar-Dayan Y; Froy O
Diabetes Care; 2015 Oct; 38(10):1820-6. PubMed ID: 26220945
[TBL] [Abstract][Full Text] [Related]
5. Tighter control of postprandial hyperglycemia with mitiglinide/voglibose fixed-dose combination in Japanese patients with type 2 diabetes mellitus.
Inoue M
Expert Opin Pharmacother; 2012 Nov; 13(16):2257-68. PubMed ID: 22994875
[TBL] [Abstract][Full Text] [Related]
6. A high-protein breakfast induces greater insulin and glucose-dependent insulinotropic peptide responses to a subsequent lunch meal in individuals with type 2 diabetes.
Park YM; Heden TD; Liu Y; Nyhoff LM; Thyfault JP; Leidy HJ; Kanaley JA
J Nutr; 2015 Mar; 145(3):452-8. PubMed ID: 25733459
[TBL] [Abstract][Full Text] [Related]
7. Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus.
Ihana-Sugiyama N; Yamamoto-Honda R; Sugiyama T; Tsujimoto T; Kakei M; Noda M
Med Sci Monit Basic Res; 2017 Feb; 23():36-44. PubMed ID: 28242866
[TBL] [Abstract][Full Text] [Related]
8. Effects of breakfast meal composition on second meal metabolic responses in adults with Type 2 diabetes mellitus.
Clark CA; Gardiner J; McBurney MI; Anderson S; Weatherspoon LJ; Henry DN; Hord NG
Eur J Clin Nutr; 2006 Sep; 60(9):1122-9. PubMed ID: 16670695
[TBL] [Abstract][Full Text] [Related]
9. Comparison of glycemic variability in patients with type 2 diabetes given sitagliptin or voglibose: a continuous glucose monitoring-based pilot study.
Seo C; Sakamoto M; Nishimura R; Tsujino D; Ando K; Morimoto A; Utsunomiya K
Diabetes Technol Ther; 2013 May; 15(5):378-85. PubMed ID: 23634671
[TBL] [Abstract][Full Text] [Related]
10. Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin.
Aoki K; Kamiyama H; Yoshimura K; Shibuya M; Masuda K; Terauchi Y
Acta Diabetol; 2012 Jun; 49(3):225-30. PubMed ID: 21898126
[TBL] [Abstract][Full Text] [Related]
11. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects.
Frid AH; Nilsson M; Holst JJ; Björck IM
Am J Clin Nutr; 2005 Jul; 82(1):69-75. PubMed ID: 16002802
[TBL] [Abstract][Full Text] [Related]
12. Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
Tsuchimochi W; Ueno H; Yamashita E; Tsubouchi C; Sakoda H; Nakamura S; Nakazato M
Endocr J; 2015; 62(1):13-20. PubMed ID: 25252844
[TBL] [Abstract][Full Text] [Related]
13. High-energy breakfast with low-energy dinner decreases overall daily hyperglycaemia in type 2 diabetic patients: a randomised clinical trial.
Jakubowicz D; Wainstein J; Ahrén B; Bar-Dayan Y; Landau Z; Rabinovitz HR; Froy O
Diabetologia; 2015 May; 58(5):912-9. PubMed ID: 25724569
[TBL] [Abstract][Full Text] [Related]
14. Comparing postprandial efficacy in type 2 diabetic patients receiving mitiglinide and sitagliptin by using continuous glucose monitoring: a pilot study.
Ando K; Nishimura R; Seo C; Tsujino D; Sakamoto M; Utsunomiya K
Expert Opin Pharmacother; 2014 Dec; 15(17):2479-85. PubMed ID: 25327311
[TBL] [Abstract][Full Text] [Related]
15. Glucose excursions and hypoglycemia in patients with type 2 diabetes treated with mitiglinide/voglibose versus glimepiride: A randomized cross-over trial.
Fujimoto K; Shibayama Y; Yamaguchi E; Honjo S; Hamasaki A; Hamamoto Y
J Diabetes; 2018 Aug; 10(8):675-682. PubMed ID: 29493100
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Efficacy of Repaglinide Versus the Combination of Mitiglinide and Voglibose on Glycemic Variability in Japanese Patients with Type 2 Diabetes.
Okada H; Tanaka M; Hasegawa G; Nakajima H; Kadono M; Okada Y; Hirata A; Oyamada H; Yamane T; Fukui M
Curr Pharm Des; 2020; 25(43):4600-4605. PubMed ID: 31538887
[TBL] [Abstract][Full Text] [Related]
17. Effects of sitagliptin or mitiglinide as an add-on to acarbose on daily blood glucose fluctuations measured by 72 h subcutaneous continuous glucose monitoring in Japanese patients with type 2 diabetes: a prospective randomized study.
Osonoi T; Saito M; Tamasawa A; Ishida H; Osonoi Y
Expert Opin Pharmacother; 2014 Jul; 15(10):1325-35. PubMed ID: 24866329
[TBL] [Abstract][Full Text] [Related]
18. The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study.
Ohkura T; Inoue K; Fujioka Y; Nakanishi R; Shiochi H; Sumi K; Yamamoto N; Matsuzawa K; Izawa S; Ohkura H; Kato M; Yamamoto K; Taniguchi S
BMC Res Notes; 2013 Nov; 6():453. PubMed ID: 24215809
[TBL] [Abstract][Full Text] [Related]
19. Restricting carbohydrates at breakfast is sufficient to reduce 24-hour exposure to postprandial hyperglycemia and improve glycemic variability.
Chang CR; Francois ME; Little JP
Am J Clin Nutr; 2019 May; 109(5):1302-1309. PubMed ID: 30968140
[TBL] [Abstract][Full Text] [Related]
20. The acute effects of dietary carbohydrate reduction on postprandial responses of non-esterified fatty acids and triglycerides: a randomized trial.
Samkani A; Skytte MJ; Anholm C; Astrup A; Deacon CF; Holst JJ; Madsbad S; Boston R; Krarup T; Haugaard SB
Lipids Health Dis; 2018 Dec; 17(1):295. PubMed ID: 30591062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
